Entity family

Browse drugs

Named medicines, compounds, vaccines, and pharmacological agents. Examples include metformin, semaglutide, antibiotics.

2articles mentioning drugs

2drug mentions

1distinct drugs extracted

0%of mentions human-reviewed

Active filtersEntity: Glypican-3 ×

Glypican-3

This drug is selected. Its supporting articles are shown below.

Glypican-32

Articles mentioning Glypican-3

2 articles · page 1 of 1

IDDF2026-ABS-0094 Clinical outcomes and safety of GPC3-directed CAR-T therapy in advanced hepatocellular carcinoma: a systematic review of early-phase trials

gutjnl · abstract · 2026-06-26 · 1 matching annotations

78.1%

GPC3 Glypican-3 Hepatocellular carcinoma HCC PubMed Chimeric antigen receptor T-cell (CAR-T) therapy GPC3-directed CAR-T therapy Google Scholar

…imeric antigen receptor T-cell (CAR-T) therapy directed against GPC3 has shown early antitumor activity in phase I trials; however, …

IDDF2026-ABS-0481 A GPC3-targeted radiotracer derived from DNA-encoded cyclic peptides library for PET imaging of hepatocellular carcinoma

gutjnl · abstract · 2026-06-26 · 1 matching annotations

75.0%

68Ga 68Ga-labelled Glypican-3 Hepatocellular carcinoma HCC HepG2

…d flow cytometry. The DOTA-conjugated peptide was labelled with 68Ga ([68Ga]CTCN) for cellular uptake and PET/CT imaging in HepG2 xe…